Skip to main content
. Author manuscript; available in PMC: 2022 Nov 14.
Published in final edited form as: Am J Hematol. 2021 Jul 28;96(10):1241–1252. doi: 10.1002/ajh.26292

Table 3.

Diagnostic Criteria for iMCD or CD

Inclusion Criteria Exclusion Criteria
Major Criteria Minor Criteria
Fajgenbaum et al. (2017) a (Mandatory)
  • Histopathologic features present in LN tissue

  • Enlarged LNs in more than one LN station

(need 2 or more of 11 with at least 1 laboratory criterion)
Laboratory
  • Elevated ESR or CRP

  • Anemia

  • Thrombocytopenia or thrombocytosis

  • Renal dysfunction or proteinuria

  • Polyclonal hypergammaglobulinemia

  • Hypoalbuminemia

Clinical
  • Constitutional symptoms

  • Splenomegaly and/or hepatomegaly

  • Fluid accumulation

  • Eruptive cherry angiomata or violaceous papules

  • Lymphocytic interstitial pneumonitis

  • Autoimmune/inflammatory disease

  • Infection-related disorders

  • Malignancy/lymphoproliferative disorders

Fujimoto et al. for CD (2018) b (Mandatory)
  • ≥1 swollen LNs
    • 1 swollen LN: UCD
    • >1 swollen LN: MCD
  • Histopathological findings of LNs or other organs that is consistent with one of the following types of CD
    • Hyaline vascular
    • Plasma cell
    • Mixed
  • Diagnosis of iMCD is after exclusion of UCD and HHV-8-positive MCD

N/A
  • Malignant neoplasms

  • Infectious diseases

  • Autoimmune diseases

  • Others (IgG4-RD, histiocytic necrotizing lymphadenitis, sarcoidosis, idiopathic portal hypertension, etc.)

Abbreviations: CD, Castleman disease; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; HHV-8, human herpesvirus-8; HIV, human immunodeficiency virus; IgG4-RD, IgG4-related diseases; LN, lymph node; UCD, unicentric Castleman disease

a

International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease. Blood. 2017 Mar 23;129(12):1646-1657.

b

Tentative diagnostic criteria and disease severity classification for Castleman disease: A report of the research group on Castleman disease in Japan. Mod Rheumatol 28(1): 161-167.